Stocktoria
HERON THERAPEUTICS, INC. /DE/ HRTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1987-08-26
HERON THERAPEUTICS, INC. /DE/ insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Duarte Ira | EVP, Chief Financial Officer | 2026-06-16 | Option exercise | 12,500 | — |
| Duarte Ira | EVP, Chief Financial Officer | 2026-06-16 | Tax withheld | 3,555 | $0.38 |
| Forbes William P | EVP, Chief Development Officer | 2026-06-06 | Option exercise | 12,500 | — |
| Hensley Mark Earl | Chief Operating Officer | 2026-05-06 | Option exercise | 125,000 | — |
| Hensley Mark Earl | Chief Operating Officer | 2026-04-30 | Option exercise | 11,770 | — |
| Forbes William P | EVP, Chief Development Officer | 2026-04-30 | Option exercise | 11,694 | — |
| Forbes William P | EVP, Chief Development Officer | 2026-04-30 | Option exercise | 11,770 | — |
| Duarte Ira | EVP, Chief Financial Officer | 2026-04-30 | Option exercise | 11,694 | — |
Source: SEC EDGAR filings · CIK 0000818033 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.